Esi M. Morgan, MD, MSCE

Assistant Clinical Director, Division of Rheumatology

Academic Affiliations

Associate Professor, UC Department of Pediatrics

Phone 513-636-4676



Childhood rheumatic diseases; juvenile idiopathic arthritis; juvenile dermatomyositis; sarcoidosis


Patient reported outcomes measure development; quality Improvement; health services research; economic evaluations; comparative effectiveness

Esi Morgan, MD, MSCE, is a pediatric rheumatologist and researcher. Clinical care spans the childhood rheumatic diseases, with focus on juvenile idiopathic arthritis (JIA) and juvenile dermatomyositis.

Her research training and experience includes epidemiology and health services research, in addition to specialization in quality improvement methods and application to improve health care delivery. Dr. Morgan leads a research project to develop new measures to assess pain in children and youth, as well as to validate measures of health related quality of life in children with juvenile idiopathic arthritis or chronic pain as part of a national network of investigators.

Dr. Morgan is a leader in a multi-center quality improvement network to improve the outcome of care in children with JIA, the Pediatric-Rheumatology Care and Outcomes Improvement Network. Additionally, she has served on expert panels in development of JIA treatment recommendations and measures of quality of care in treatment of JIA.

MD: Washington University School of Medicine, St. Louis, MO, 1999.

Residency: Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, 2002.

Fellowship: Rheumatology, Children’s Hospital of Philadelphia, Philadelphia, PA, 2005.

MSCE: University of Pennsylvania, Center for Clinical Epidemiology & Biostatistics, Philadelphia, PA, 2005.

Certification:  Pediatrics, 2002; Pediatric Rheumatology, 2006.

View PubMed Publications

Harris JG1, Bingham CA, Morgan EM. Improving care delivery and outcomes in pediatric rheumatic diseases. Curr Opin Rheumatol. 2016 Mar;28(2):110-6.

Kashikar-Zuck S, Carle A, Barnett K, Goldschneider KR, Sherry DD, Mara CA, Cunningham N, Farrell J, Tress J, DeWitt EM. Longitudinal evaluation of patient-reported outcomes measurement information systems measures in pediatric chronic pain. Pain. 2016 Feb;157(2):339-47.

Jacobson CJ Jr, Kashikar-Zuck S, Farrell J, Barnett K, Goldschneider K, Dampier C, Cunningham N, Crosby L, DeWitt EM. Qualitative Evaluation of Pediatric Pain Behavior, Quality, and Intensity Item Candidates and the PROMIS Pain Domain Framework in Children With Chronic Pain. J Pain. 2015 Dec;16(12):1243-55.

DeWalt DA1, Gross HE, Gipson DS, Selewski DT, DeWitt EM, Dampier CD, Hinds PS, Huang IC, Thissen D, Varni JW. PROMIS® pediatric self-report scales distinguish subgroups of children within and across six common pediatric chronic health conditions. Qual Life Res. 2015 Sep;24(9):2195-208.

Varni JW, Thissen D, Stucky BD, Liu Y, Magnus B, He J, DeWitt EM, Irwin DE, Lai JS, Amtmann D, DeWalt DA. Item-level informant discrepancies between children and their parents on the PROMIS® pediatric scales. Qual Life Res. 2015 Aug;24(8):1921-37.

Jensen RE, Rothrock NE, DeWitt EM, Spiegel B, Tucker CA, Crane HM, Forrest CB, Patrick DL, Fredericksen R, Shulman LM, Cella D, Crane PK. The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care. Med Care. 2015 Feb;53(2):153-9.

Broderick JE, DeWitt EM, Rothrock N, Crane PK, Forrest CB. Advances in Patient Reported Outcomes: The NIH PROMIS Measures. EGEMS (Wash DC). 2013 Aug 2;1(1):1015.

Lipstein EA, Brinkman WB, Sage J, Lannon CM, Morgan Dewitt E. Understanding treatment decision making in juvenile idiopathic arthritis: a qualitative assessment. Pediatr Rheumatol Online J. 2013 Sep 30;11(1):34.

Ringold S, Weiss PF, Colbert RA, DeWitt EM, Lee T, Onel K, Prahalad S, Schneider R, Shenoi S, Vehe RK, Kimura Y; Juvenile Idiopathic Arthritis Research Committee of the Childhood Arthritis and Rheumatology Research Alliance. Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2014 Jul;66(7):1063-72.

DeWitt EM, Li Y, Curtis JR, Glick HA, Greenberg JD, Anstrom KJ, Kremer JM, Reed G, Schulman KA, Reed SD. Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis: Methodological Considerations. J Rheumatol. 2013 Feb;40(2):127-36.

Patient Centered Adaptive Treatment Strategies (PCATS) using Bayesian Causal Inference. Co-Investigator. PCORI Patient-Centered Outcomes Research Institute. Sept 2015-Aug 2018. ME-1408-19894.

Patients, Advocates and Rheumatology Teams Network for Research and Service (PARTNERS) – Phase II. Co-Investigator. PCORI Patient-Centered Outcomes Research Institute. Sept 2015-Sept 2018. PPRN-1306-04601.